• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CDC: Weekly Viral Respiratory Illness Snapshot. December 1st, 2023.

Mary Wilson

Well-known member
Reported on Friday, December 1st, 2023.

Note: data summaries are based on CDC subject matter expert interpretation of publicly available findings across multiple data systems, some of which are not included in the data visualizations on these web pages.

The amount of respiratory illness (fever plus cough or sore throat) causing people to seek healthcare is increasing across most areas of the country.

The U.S. is experiencing elevated RSV activity, particularly among young children. After a period of limited change, COVID-19 activity is increasing again especially in the Midwest and Mid-Atlantic regions. Influenza activity continues to increase in most of the country. Hospital bed occupancy for all patients, including within intensive care units, remains stable nationally; however, pediatric inpatient bed occupancy has been increasing. Vaccines are available and can help protect people from the most serious health effects of fall and winter viruses.
  • COVID-19 test positivity (percentage of tests conducted that were positive), emergency department visits, and hospitalizations have increased nationally.  A group of Omicron variants (XBB and its sublineages) are the predominant lineages detected in the U.S., with HV.1 being most common. The prevalence of another lineage, BA.2.86, is projected to account for 5-15% of currently circulating variants. CDC continues to monitor HV.1, BA.2.86, and all other lineages.
  • National test positivity, emergency department visits, and hospitalizations for influenza continue to increase.
  • RSV emergency  department visits and hospitalizations continue to increase across the country. RSV-associated hospitalization rates remain elevated among young children and are increasing among older adults; of note, only 14.8% of adults 60+ report having received an RSV vaccine.
  • National vaccination coverage for COVID-19, influenza, and RSV vaccines increased less than one percentage point for children and adults, where indicated, compared to the previous week and remains low for both groups.
  • CDC has been monitoring increases in respiratory illness reported recently among children, including potential elevated rates of pediatric pneumonia in parts of the United States. These reported increases do not appear to be due to a new virus or other pathogen but to several viral or bacterial causes that we expect to see during the respiratory illness season. CDC will continue to work closely with our state and local public health partners to maintain strong situational awareness and will provide updates, as needed.
https://www.cdc.gov/respiratory-viruses/data-research/dashboard/snapshot.html
 
Back
Top